宜宾有隆胸医院吗(宜宾那做双眼皮做的好) (今日更新中)

BEIJING, Jan. 3 (Xinhua) -- A collection of China's nine white papers issued in 2011 has been published in both Chinese and English, according to a statement issued by the publisher on Tuesday.By giving a clear and precise illustration of China's policies, principles and progress in subjects like national defense, law, climate change and international trade, the white papers can help the world know about, and understand, China, the statement said.The white papers are titled, "China's National Defense in 2010," "China's Foreign Aid," "Sixty Years Since the Peaceful Liberation of Tibet," "China's Peaceful Development," "The Socialist System of Laws with Chinese Characteristics," "New Progress in Development-oriented Poverty Reduction Program for Rural China," "China's Policies and Actions for Addressing Climate Change (2011)," "China's Foreign Trade" and "China's Space Activities in 2011."The white papers were all published by the Information Office of the State Council on behalf of the Chinese government.The latest one on space activities was issued last Thursday.

TEL AVIV, Jan. 25 (Xinhua) -- Israeli Prime Minister Benjamin Netanyahu on Tuesday praised the relations between Israel and China at a reception celebrating the 20th anniversary of the establishment of diplomatic ties between the two countries."We may be celebrating 20 years of relations, but our peoples are now celebrating a thousand years of friendship," Netanyahu said.He mentioned China's fair treatment towards the Jewish communities in the past, and the safe-haven given to them during the holocaust. "Like the Chinese people, the Jewish people have a long memory. We always remember our friends. We always remember people who extended a hand to us in our darkest days and we are grateful for China for that."Israli Prime Minister Benjamin Netanyahu (R) speaks at a reception celebrating the 20th anniversary of the establishment of diplomatic ties between China and Israel in Tel Aviv on Jan. 24, 2012.The prime minister said that the friendship between the two sides can further deepen. "I think we barely scratched the surface of Israeli-Chinese relations. I have no doubt that in the coming years we'll see a dramatic expansion of these ties," he said."We've talked about doubling the trade (between the two countries). Well, I'd like to see a doubling of a doubling of the trade. I think Israel and China together are a winning combination, " Netanyahu said.In addition to the prime minister, several other senior Israeli officials attended the reception, among them ministers, former ambassadors and envoys to China and key figures in the bilateral ties.Chinese ambassador Gao Yanping said that "Over the past 20 years our pragmatic cooperation has been booming. When we started our diplomatic relations in 1992, our two-way trade volume was only a little bit more than 50 million U.S. dollars. Now the trade volume we have in two days equals that of the whole year of 1992."She said that "The further development of China-Israel relations is not only beneficial to both countries and the two peoples, but also very much conductive to regional stability, world peace and global prosperity.""Facing the ongoing major transformation and adjustment in the region and in the world, the China-Israel relationship is now at a new historical point. We should continue to work together, grow together and succeed together in the years to come," Gao added.

BEIJING, Dec. 2 (Xinhua) -- Medical experts and leaders from the world's leading orthopaedic societies on Friday called for the improvement of health insurance programs and medical care for people in developing countries."Health care should reach the unreached," said Professor H.K.T. Raza, president of the Asia Pacific Orthopaedic Association (APOP), at the Sixth International Congress of Chinese Orthopaedic Association (COA), which is running from Thursday to Sunday in Beijing."If we really want to improve people's well-being, we have to make health care available to those who have difficulty accessing it. Although that will probably be a very difficult task, we should try and do it gradually," said Professor K.M. Chan from the Prince of Wales Hospital in Hong Kong.Statistics from the Ministry of Health show that 1.27 billion Chinese, or 95 percent of the country's population, are covered by basic medical insurance programs.However, private medical insurance accounts for less than 2 percent of the country's health care financing, while private insurance in other countries stands at an average of 20 percent."With the increasing demand for quality health care, there will be higher demand for commercial insurance. With more private health funding in the system, we can increase the quality," Prof. Chan said.Government health care expenditures should be directed toward those who can't afford health care at all, while commercial insurance should cover the needs of those who can afford to purchase it, Prof. Chan said."We need to have different approaches combined together to revamp the current health insurance structure in China," he said."If you want to raise the quality of health care, you need to have the responsibility from the government, the individuals and the insurance system," he added.While China may need to promote its commercial health insurance, in India, the situation is different. Though many medical tourists choose India as their destination for affordable care, health insurance is uncommon in the country.While patients typically pay out of their own pockets for routine care, it is estimated that over 300 million Indians out of a population of 1.2 billion still live on less than one U.S. dollar per day.

WASHINGTON, Oct. 13 (Xinhua) -- U.S. researchers have corrected sickle cell disease in adult laboratory mice that had been bred to have the inherited blood disorder by activating production of a special blood component, according to a study published online Thursday in the journal Science.Sickle cell disease results from an abnormality in hemoglobin, the protein found in red blood cells that is responsible for transporting oxygen throughout the body. People living with sickle cell disease have two copies of an altered gene that produces sickle hemoglobin instead of normal adult hemoglobin. Sickle hemoglobin changes shape after releasing its oxygen, causing the red blood cell to become stiff, misshapen and sticky, and slowing blood flow to tissues. This process damages organs and causes pain.The study tested a new approach to increasing the production of a third form of hemoglobin -- fetal hemoglobin. Production of fetal hemoglobin predominates before birth, but turns off thereafter as adult hemoglobin production takes over. People with sickle cell disease are unable to make normal adult hemoglobin, and instead make sickle hemoglobin starting in infancy.An elevated level of fetal hemoglobin within the red blood cell reduces the tendency of sickle hemoglobin to change the shape of red blood cells. Considerable research has shown that the drug hydroxyurea increases production of fetal hemoglobin and reduces the number of pain crises and other complications of sickle cell disease in adults and children. However, not all patients respond well to hydroxyurea, and adverse side effects are a concern.The current study explores a more targeted approach to increasing fetal hemoglobin production. It builds upon earlier studies that discovered a protein called BCL11A normally suppresses the production of fetal hemoglobin soon after birth. The researchers viewed the BCL11A protein as a target for therapy and decided to see what would happen if they blocked production of the protein.The paper details how the research team silenced the mouse gene that produces the BCL11A protein in mice with sickle cell disease. Silencing the gene turned off production of the BCL11A protein and allowed the adult mice to continue to produce fetal hemoglobin. It appears to have eliminated disease symptoms without affecting other aspects of blood production."This discovery provides an important new target for future therapies in people with sickle cell disease," said Susan Shurin, acting director of the U.S. National Heart, Lung, and Blood Institute, which co-funded the study. "More work is needed before it will be possible to test such therapies in people, but this study demonstrates that the approach works in principle."Approximately 100,000 Americans live with sickle cell disease. It is most prevalent in people of African, Hispanic, Mediterranean, and Middle Eastern descent. There is no widely available cure for sickle cell disease. Bone marrow transplants have cured some patients, but the treatment is not without risk and most patients do not have relatives who can donate compatible and healthy bone marrow to them.

来源：资阳报